Creative Medical Technology Holdings announced recruitment of Courtney Bartlett to lead clinical development of the Company's pipeline of therapeutic products. Bartlett has been heading clinical research efforts for more than a decade in the area of cell and gene therapy. She was co-Investigator on several widely publicized stem cell clinical trials performed by public companies such as Capricor, TEVA, VeriCel, and Astellas. Additionally, she has published numerous articles, book chapters and poster presentations in the area of regenerative medicine.